Navigation Links
Study finds drug may cut down involuntary movements

The medication tetrabenazine cut down involuntary movement in patients with Huntington's disease on average by about 25 percent, with many patients experiencing a greater improvement, according to a study in the February 14 issue of the journal Neurology.

Overall, patients who received the medication were six times as likely to be considered by their doctors to have improved considerably, compared to participants who received a placebo.

Dr. Kathleen M. Shannon, neurologist and Huntington's disease specialist at the Huntington's Disease Society of America Center of Excellence at Rush University Medical Center, led the Rush study. Rush was one of 16 sites to participate in the randomized, controlled study which involved 84 patients.

Tetrabenazin is available in Europe and Canada ?but not the United States, but is currently being reviewed by the U.S. Food and Drug Administration. If approved, the medication would be the first authorized by the agency expressly for the treatment of Huntington's disease, which affects about 30,000 people in the United States.

"Huntington's disease is an inherited brain disorder that causes patients to experience uncontrollable jerky movements (chorea), as well as changes in personality, behavior, thinking and memory. There are no FDA-approved treatments for the chorea. Anti-psychotic drugs like haloperidol (Haldol) are commonly used to suppress chorea, but they cause many different side effects. This study shows that tetrabenazine can decrease chorea, and the drug is well-tolerated by most research subjects," said Shannon.

Tetrabenazine was originally developed in the 1950s to treat psychosis, but was quickly pushed aside by more effective medications. But doctors in the United Kingdom found it to be effective to treat the excessive involuntary movements of Huntington's, and it is approved for use in several nations. In the United States, tetrabenazine is designated as an "orphan drug" by the FD
'"/>

Source:Rush University Medical Center


Page: 1 2 3

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:
(Date:7/25/2008)...ton department of health and human performance is ...L) thanks to grants from the UH Faculty Developmen...e Project of the University of Southern California...nds will allow our faculty to stake ground in Seco...mmunity," said Charles Layne, professor and depart...
(Date:7/25/2008).... The life expectancy for patients with human imm...an 13 years since the late 1990s thanks to advance...archers at the University of Alabama at Birmingham...ritish Columbia. , Improved survival has led to ...55 HIV-positive study participants in Europe and N...
(Date:7/25/2008)...dren born with hydrocephalus, or "water on the bra...away from the brain to reduce harmful pressure. ,...nt infection in children is very high for a variet...ough another surgery to replace the shunt, bringin... neurological complications and an increased risk ...
(Date:7/25/2008)...) New research published in the July issue of the...ws elevated plasma DNA is a reliable marker of rec...that plasma DNA levels rise before clinical eviden...s. , Esophageal cancer, one of the leading cau...d at a late stage. An accurate marker for detectin...
Breaking Biology News(10 mins):Second Life a first for UH department of health and human performance 2Anti-HIV therapy boosts life expectancy more than 13 years 2Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Plasma DNA level is a reliable marker of recurrent esophageal cancer, study finds 2BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 1BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 2BioMed Realty Trust Announces Exercise of Over Allotment Option for Common Stock 4777 3UltraTape Announces Sample Kits Available for Purchase Through Website 4774 1UltraTape Announces Sample Kits Available for Purchase Through Website 4774 2Disparities in Life Expectancy Increasing 17444 1Disparities in Life Expectancy Increasing 17444 2Disparities in Life Expectancy Increasing 17444 3Phone counseling improves quality of life immune systems of cervical cancer survivors 17441 1Phone counseling improves quality of life immune systems of cervical cancer survivors 17441 2
...titute for Biological Studies have identified an i...the speed with which our leg muscles contract and ...in understanding the neural circuitry that coordin... in developing new treatments for spinal cord inju...understanding how they control the essential aspec...
...ith hepatitis C virus (HCV) achieved significantly...mmunosuppressive agent Cyclosporine along with int...e also showed efficacy against Hepatitis C virus i...e January 2006 issue of Liver Transplantation, the...the Study of Liver Diseases (AASLD) and the Intern...
... very few of the available mutational pathways to ...versity have found in a study of a gene whose muta... prescribed antibiotic by a factor of roughly 100,...ive-step mutational paths that theoretically could...ly endow bacteria with a meaningful evolutionary a...
...lved together over millions of years in a game of ... or worse. , Now, a University of California, Berk...case, a benign one - can be forced to evolve in wa...s, or AAV, is a common, though innocuous, resident...in recent years as a possible carrier for genes in...
Other Biology News:Salk researchers make fast strides towards understanding how our body controls walking 2Cyclosporine inhibits hepatitis C virus in vitro 2Evolution follows few of the possible paths to antibiotic resistance 2Scientists force viruses to evolve as better delivery vehicles for gene therapy 2Scientists force viruses to evolve as better delivery vehicles for gene therapy 3
(Date:7/24/2008)...ly 24 /- The Global Probiotics Counci... DANONE and Yakult Honsha,Co., Ltd., announced the...,Investigator Grant for Probiotics Research (YIGPR...g rising stars who will continue to contribute to,...esearch in the United,States., Ajay S. Gulati, MD...
(Date:7/24/2008)..., Calif., July 24 /- Poniar...rmaceutical company focused,on oncology, today ann...uss,the Company,s second quarter results and provi...clinical development plan for picoplatin, the,Comp..., chairman and chief,executive officer, Ronald A. ...
(Date:7/24/2008)...y 24 /- Cara Therapeutics, Inc.,annou...additional funding,to its original $24 million Ser...ound was led by new investor, Devon Park Bioventur...vations. Previous investors participating,in the r...shi International,Corporation and Wistar Morris. I...
(Date:7/24/2008)...uly 24 /- Sagent Pharmaceuticals, Inc...ny, today announced that it,has launched ceftazidi...rum, beta-lactam antibiotic. Sagent will offer cef...macy bulk package vials. According to,IMS data, 20...ates were,approximately $45.7 million., "Sagent i...
Breaking Biology Technology:Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 2Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 3Global Probiotics Council Announces First Awardees for New Young Investigator Grant for Probiotics Research 4Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Cara Therapeutics Secures $12.3 Million in Series C Extension Financing 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2
...Wis . - Employers who are looking for health infor...n healthcare premiums will have to wait a while lo...th information management organization. , ,Stephen...rmation and Management Systems Society , said imp...interoperability between facilities remain high IT...
...s, Wis. - Wisconsin attracts far fewer defense re... and Colorado, but a number of public and private ... bastion for high-tech national security projects....ve as the war on terrorism unfolds and the nation ..., president of the Wisconsin Technology Council ,...
...s. - Last Sunday morning, in the free-wheeling en...or Lynnanne Huber shared secrets and strategies fr...on the Internet, which she expects to publish nex...non-conference" for Wisconsin technology professio...iency and minimizing hurt feelings in the sometime...
...k ago, 67 companies were nervously introducing the...business development executives, early adopters, a...ent. The on-stage demos were nearly flawless. John...in the pavilion was cacophonic. Heck, even the Wi-...s as the 67 companies delivered amazing products t...
Other Biology Technology:CEO of healthcare group still hopeful IT will save employers money 2CEO of healthcare group still hopeful IT will save employers money 3Chippewa Valley firms land more defense work 2Chippewa Valley firms land more defense work 3Chippewa Valley firms land more defense work 4Chippewa Valley firms land more defense work 5Chippewa Valley firms land more defense work 6Chippewa Valley firms land more defense work 7BarCamp talk turns to Internet dating 2BarCamp talk turns to Internet dating 3Basking (briefly) in the DEMOfall 2006 glow 2
...Permeabilisation medium LEUCOPERM reagents are in... A and then permeabilising the cells with Reagent ...cellular structures and leaves the morphological s...ic formulations reduce background staining and all...
... pH 9.9 solution is intended for heat-induced targ... procedures. It is for use on formalin-fixed, para...des. For particular antigens, target retrieval at ...e noted that also endogenous biotin is effectively...
...entrated x 10 This pH 9.9 solution is intended fo...tochemical staining procedures. It is for use on f...ounted on glass slides. For particular antigens, t...ective. It should be noted that also endogenous bi...
The BioLogic Maximizer kit, 110 to 220 V, enables buffer blending and pH monitoring and doubles flow rates and valve capacity of BioLogic DuoFlow chromatography systems. The kit includes the Maximize
Biology Products: